#GIS2025 was a resounding success!! Immunologists, researchers, & students from around the globe united to make this an unforgettable event. A huge thank you to all the speakers and attendees who made it possible. Department of Biotechnology Rajesh Gokhale G Karthikeyan Amit Awasthi

Gut commensals-derived succinate impels colonic inflammation in ulcerative colitis #IBD nature.com/articles/s4152…

Researchers at the BRIC DBT-THSTI have shown that #colitis is associated with an increase in succinate-producing gut bacteria underscoring the role of #gut microbiota-derived succinate in driving colitogenic T cells and its potential as a therapeutic target for treating

Recent paper from our laboratory.

"Announced major policy reforms to enhance 'Ease of Innovation', 'Ease of Research' and 'Ease of Science'. Such pathbreaking decisions could not have been possible without the personal indulgence and support of PM Narendra Modi . Research Institutions allowed Non-GeM procurement

IUIS and its Early Career Committee are thrilled to announce the IUIS #RisingStars2025 Cohort! 🌟 loom.ly/f5Gq1f8 Fifteen exceptional early-career scientists from across the globe to join our #RisingStars Program Don’t miss your chance to meet them loom.ly/CwagY2g

👏Dr. Srikanth Sadhu, Research Scientist at DBT-THSTI has been selected for the prestigious International Union of Immunological Societies (#IUIS2025) rising stars awards! #RisingStars2025 Dr. Sadhu will present his work at the 19th IUIS, taking place in Vienna, Austria,

Did a walkthrough of the upcoming state-of-the-art, first-of-its-kind “Medical Research Centre” (MRC) at Translational Health Science & Technology Institute (THSTI), Faridabad — a flagship initiative supported by Department of Biotechnology. This 50-bed facility will facilitate translational

BIO-PHARMA: Miltenyi Biotec has signed a Letter of Intent with DBT-THSTI to establish India’s first hands-on training program in clinical cell manufacturing. Click to read: biovoicenews.com/miltenyi-biote… Department of Biotechnology DBT-BIRAC #CGT #genetherapy #biopharma #biovoicenews

📢Nature Index (India) 2024-25 rankings are out iBRIC+ is ranked number 3 in the Health Sciences category and DBT-THSTI remains the premier institute for translational health science research in the country, contributing to more than half (5 out of 9) of the health

👏Dr. Rajdeep Dalal, Research Scientist rajdeep dalal working with Prof Amit Awasthi Amit Awasthi of DBT-THSTI, was honored as a "Young Investigator (Cross Asia Pacific) 2025" by the World Immunotherapy Council! He presented his work on 'Dietary Micronutrients and

👉A new study reveals how testosterone suppresses Th17 cells, a key driver of skin inflammation. It binds to RORγt, inhibiting gene expression and reducing inflammation in a psoriasis model. This offers a new explanation for gender bias observed in organ-specific autoimmune

Thrilled to be driving this forward! DBT-THSTI teams' expertise led by Prof Amit Awasthi Amit Awasthi is focused on making sure these advanced CAR-T therapies are not just groundbreaking but also affordable and accessible to the public. Quality is our priority, and

I am grateful and humbled for this recognition Jyotiraditya M. Scindia Kiran Mazumdar-Shaw CSIR, India Department of Biotechnology DSTIndia

Join us for a symposia and hands-on training workshop on CAR-T Cell Therapy Manufacturing at DBT-THSTI from Nov 11-14, 2025. The workshop is in collaboration with Miltenyi Biotec. Visit the link for full details on the agenda, venue, and fees: 🔗thsti.in/CGTP/

👏Congratulations to Prof Amit Awasthi Amit Awasthi for receiving the award from Sun Pharma Science Foundation in Medical Sciences-Basic research category! This award is in recognition of his impactful contributions to Immunology Research. Department of Biotechnology BRIC DBT Rajesh Gokhale

🧵 1/2 Cell & Gene Therapy (CGT) capacity building in India! 🇮🇳 DBT-THSTI, DBT-BIRAC, and Miltenyi Biotec successfully hosted a powerful symposia today, uniting clinicians, academics, and industry leaders. Key focus: Developing indigenous CGT constructs and fostering an

🧵 2/2 The momentum continues with a 3-day hands-on CAR-T manufacturing workshop (12-14 Nov 2025)! This first-of-its-kind training blends Miltenyi University online modules with immersive practical sessions at THSTI's facility. Participants get end-to-end exposure to CGT

🚨 A landmark paper for T cell researchers! Since T cell subsets possess immense heterogeneity, having defined guidelines is critical. Leaders of the field came together to create this pivotal consensus statement. Proud contribution by Dr. Amit Awasthi (Amit Awasthi) from

Thank you, Sun Pharma Foundation, for this recognition. I am deeply grateful to all my students, and research scholars for their invaluable contributions throughout this journey. My heartfelt thanks to my family, friends, and mentors for their unwavering support. DBT-THSTI